Clinical Trials Logo

Clinical Trial Summary

The intrauterine device (IUD) is a long-acting, highly effective, reversible contraceptive method that may be underutilized due to fear of pain during insertion. Although providers frequently prescribe non-steroidal anti-inflammatory drugs (NSAIDs) for IUD insertion, there is no evidence for any pain reduction. Women can experience high levels of pain when the IUD is placed inside the uterus, and fear of this pain could be a reason that women decide not to use this method.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02708251
Study type Interventional
Source Assiut University
Contact
Status Completed
Phase Phase 4
Start date October 2016
Completion date June 2017

See also
  Status Clinical Trial Phase
Completed NCT02141321 - Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section Phase 2/Phase 3
Not yet recruiting NCT03473717 - Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method N/A
Recruiting NCT05204979 - Vaginal Vs Subling Misoprost Before Iud Insertion in Women With Previous CS
Completed NCT02738203 - Self-Administered Lidocaine Gel for Pain Management With IUD Insertion Phase 3
Completed NCT04441333 - Usability, Safety and Efficacy of AspivixTM N/A
Completed NCT02904915 - Paracervical Block Versus No Paracervical Block During IUD Insertion Phase 4
Completed NCT04046302 - Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. Phase 4
Completed NCT04441281 - Usability, Safety and Efficacy of AspivixTM (Comparative Study) N/A